CTEPH is the result of multiple or recurrent blood clots in the lungs, also known as pulmonary embolism (PE). The clot(s) and resulting scar tissue limit the blood flow to the arteries in the lungs, leading to PH, strain and eventually failure of the right-side of the heart. While all types of PH share some common characteristics, there are certain differences that occur with CTEPH. It is not the same of other forms, such as the more commonly known pulmonary arterial hypertension (PAH).

What is Chronic Thromboembolic Pulmonary Hypertension (CTEPH)?

Adapted from a patient education brochure produced by Patient and Family Education Program.

© University Health Network, Patient and Family Education

Information for patients and families

Click on the headings below to learn:

  • what CTEPH is;
  • how CTEPH is treated;
  • and which clinics specialize in the treatment of CTEPH.

CTEPH Explained by Specialists

Dr. Sanjay Mehta, Leading PH Specialist, Talks About CTEPH

Anastasia Bykova, Nurse Practitioner, Explains How CTEPH May Be Curable

Read Anastasia Bykova's article, "CTEPH: Curable Type of Pulmonary Hypertension," online (article initially published in Connections Magazine, Spring 2016. Vol. 7, No. 1).




PHA Canada thanks Bayer for its support developing this educational website. Corp-Logo_BG_Bayer-Cross-LType_Basic_72dpi_on-screen_RGB.png

Bayer Inc. is required by Health Canada to collect and report any details of adverse events and product technical complaints related to its own products that are raised and/or monitored in relation to or through this website.